CI Investments Inc
XBI icon

CI Investments Inc’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CI Investments Inc’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71M Buy
23,473
+94
+0.4% +$12.7K 0.01% 393
2026
Q1 		$2.99M Sell
23,379
-38,494
-62% -$4.81M 0.01% 350
2025
Q4 		$7.54M Buy
+61,873
New +$7.09M 0.03% 248
2025
Q1 		– Sell
-73,906
Closed -$6.66M – 1327
2024
Q4 		$6.66M Sell
73,906
-1,070,339
-94% -$104M 0.03% 276
2024
Q3 		$113M Sell
1,144,245
-93,964
-8% -$9.23M 0.43% 51
2024
Q2 		$115M Sell
1,238,209
-101,231
-8% -$9.08M 0.45% 45
2024
Q1 		$127M Buy
1,339,440
+1,286,041
+2,408% +$119M 0.5% 39
2023
Q4 		$4.77M Buy
53,399
+5,228
+11% +$388K 0.02% 281
2023
Q3 		$3.52M Hold
48,171
– – 0.02% 288
2023
Q2 		$4.01M Hold
48,171
– – 0.02% 284
2023
Q1 		$3.67M Hold
48,171
– – 0.02% 290
2022
Q4 		$4M Sell
48,171
-10,000
-17% -$810K 0.02% 292
2022
Q3 		$4.61M Sell
58,171
-15,000
-20% -$1.26M 0.02% 293
2022
Q2 		$5.43M Buy
73,171
+21,081
+40% +$1.58M 0.03% 273
2022
Q1 		$4.68M Buy
52,090
+51,890
+25,945% +$4.79M 0.02% 328
2021
Q4 		$22K Buy
+200
New +$24.1K ﹤0.01% 1073
2019
Q1 		– Sell
-414,083
Closed -$29.7M – 374
2018
Q4 		$29.7M Sell
414,083
-136,517
-25% -$11M 0.19% 129
2018
Q3 		$52.8M Sell
550,600
-23,000
-4% -$2.23M 0.4% 77
2018
Q2 		$54.6M Sell
573,600
-23,300
-4% -$2.14M 0.43% 72
2018
Q1 		$52.4M Buy
+596,900
New +$54.5M 0.6% 54

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

CI Investments Inc's XBI Position: Q2 2026 in Review

CI Investments Inc increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.4% in Q2 2026, buying an estimated $12.7K and bringing the position to 23,473 shares worth $3.71M. The position accounts for 0.01% of the portfolio, ranked #393.

CI Investments Inc first reported a position in XBI in Q1 2018 and has held it in 20 quarters since. The position peaked at $127M in Q1 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • CI Investments Inc held 23,473 shares of State Street SPDR S&P Biotech ETF worth $3.71M as of Q2 2026.
  • CI Investments Inc bought 94 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $12.7K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of CI Investments Inc's portfolio in Q2 2026, its #393 holding.
  • CI Investments Inc first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 20 quarters since.
  • CI Investments Inc's State Street SPDR S&P Biotech ETF position peaked at $127M in Q1 2024.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.